UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 131

Sortiert nach

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis

The Lancet (British edition), 2008-11, Vol.372 (9653), p.1894-1905

2008

Link zum Volltext

Verfügbarkeit prüfen

Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine

Proceedings of the National Academy of Sciences - PNAS, 2013-12, Vol.110 (51), p.E4997-E5005

2013

Link zum Volltext

Verfügbarkeit prüfen

Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge

Proceedings of the National Academy of Sciences - PNAS, 2010-08, Vol.107 (31), p.13701-13706

2010

Link zum Volltext

Verfügbarkeit prüfen

Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors

Annual review of medicine, 2004-01, Vol.55 (1), p.355-372

2004

Link zum Volltext

Verfügbarkeit prüfen

Safety and Immunogenicity of a Replication-Incompetent Adenovirus Type 5 HIV-1 Clade B gag/pol/nef Vaccine in Healthy Adults

Clinical infectious diseases, 2008-06, Vol.46 (11), p.1769-1781

2008

Link zum Volltext

Verfügbarkeit prüfen

Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus

Vaccine, 2012-12, Vol.30 (52), p.7469-7474

2012

Link zum Volltext

Verfügbarkeit prüfen

oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions

Proceedings of the National Academy of Sciences - PNAS, 2008-10, Vol.105 (41), p.15684-15689

2008

Link zum Volltext

Verfügbarkeit prüfen

Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step study

PloS one, 2011-06, Vol.6 (6), p.e20479-e20479

2011

Link zum Volltext

Verfügbarkeit prüfen

An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoV

Emerging microbes & infections, 2023-12, Vol.12 (2), p.2275598-2275598

2023

Link zum Volltext

Verfügbarkeit prüfen

PD-1 Blockade in Rhesus Macaques: Impact on Chronic Infection and Prophylactic Vaccination

The Journal of immunology (1950), 2009-01, Vol.182 (2), p.980-987

2009

Link zum Volltext

Verfügbarkeit prüfen

Fully Synthetic Carbohydrate HIV Antigens Designed on the Logic of the 2G12 Antibody

Journal of the American Chemical Society, 2007-09, Vol.129 (36), p.11042-11044

2007

Link zum Volltext

Verfügbarkeit prüfen

Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates

Proceedings of the National Academy of Sciences - PNAS, 2010-06, Vol.107 (23), p.10655-10660

2010

Link zum Volltext

Verfügbarkeit prüfen

Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus

Virology (New York, N.Y.), 2009-03, Vol.385 (1), p.218-226

2009

Link zum Volltext

Verfügbarkeit prüfen

DNA gag/Adenovirus Type 5 (Ad5) gag and Ad5 gag/Ad5 gag Vaccines Induce Distinct T-Cell Response Profiles

Journal of Virology, 2008-08, Vol.82 (16), p.8161-8171

2008

Link zum Volltext

Verfügbarkeit prüfen

Comparative Cell-Mediated Immunogenicity of DNA/DNA, DNA/Adenovirus Type 5 (Ad5), or Ad5/Ad5 HIV-1 Clade B gag Vaccine Prime-Boost Regimens

The Journal of infectious diseases, 2010-01, Vol.201 (1), p.132-141

2010

Link zum Volltext

Verfügbarkeit prüfen

Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay

Journal of acquired immune deficiency syndromes (1999), 2007-05, Vol.45 (1), p.20

2007

Link zum Volltext

Verfügbarkeit prüfen

All for one and one for all to fight flu

Nature (London), 2019-01, Vol.565 (7737), p.29-31

2019

Link zum Volltext

Verfügbarkeit prüfen

A replication-defective human cytomegalovirus vaccine for prevention of congenital infection

Science translational medicine, 2016-10, Vol.8 (362), p.362ra145

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Multivalent Adenovirus-Based Vaccine against Simian Immunodeficiency Virus Challenge

Journal of Virology, 2010-03, Vol.84 (6), p.2996-3003

2010

Link zum Volltext

Verfügbarkeit prüfen

Safety and Immunogenicity of the Merck Adenovirus Serotype 5 (MRKAd5) and MRKAd6 Human Immunodeficiency Virus Type 1 Trigene Vaccines Alone and in Combination in Healthy Adults

Clinical and Vaccine Immunology, 2009-09, Vol.16 (9), p.1285-1292

2009

Link zum Volltext

Verfügbarkeit prüfen

The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat

Proceedings of the National Academy of Sciences - PNAS, 2021-01, Vol.118 (3)

2021

Link zum Volltext

Verfügbarkeit prüfen

Vectored Gag and Env but Not Tat Show Efficacy against Simian-Human Immunodeficiency Virus 89.6P Challenge in Mamu-A01-Negative Rhesus Monkeys

Journal of Virology, 2005-10, Vol.79 (19), p.12321-12331

2005

Link zum Volltext

Verfügbarkeit prüfen

Developing Vaccines for SARS-CoV-2 and Future Epidemics and Pandemics: Applying Lessons from Past Outbreaks

Health security, 2020-06, Vol.18 (3), p.241

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 131

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(128)
Mit Volltextzugriff
(114)

Publikationsform

Artikel
(130)
Buchkapitel
(1)

Sprache

Englisch
(131)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

Science & Technology
(108)
Life Sciences & Biomedicine
(92)
Animals
(74)
Humans
(65)
Biological And Medical Sciences
(55)
Virology
(54)
Fundamental And Applied Biological Sciences. Psychology
(46)
Immunology
(42)
Macaca Mulatta
(41)
Microbiology
(41)
Aids Vaccines - Immunology
(35)
Hiv-1 - Immunology
(34)
Human Immunodeficiency Virus
(33)
Human Immunodeficiency Virus 1
(30)
Miscellaneous
(30)
Vaccines
(30)
Hiv
(29)
Female
(28)
Mice
(26)
Vaccines, Antisera, Therapeutical Immunoglobulins And Monoclonal Antibodies
(26)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis

Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine

Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge

Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors

Safety and Immunogenicity of a Replication-Incompetent Adenovirus Type 5 HIV-1 Clade B gag/pol/nef Vaccine in Healthy Adults

Low-Dose Penile SIVmac251 Exposure of Rhesus Macaques Infected with Adenovirus Type 5 (Ad5) and Then Immunized with a Replication-Defective Ad5-Based SIV gag/pol/nef Vaccine Recapitulates the Results of the Phase IIb Step Trial of a Similar HIV-1 Vaccine

Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus

oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions

Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step study

An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoV

PD-1 Blockade in Rhesus Macaques: Impact on Chronic Infection and Prophylactic Vaccination

Fully Synthetic Carbohydrate HIV Antigens Designed on the Logic of the 2G12 Antibody

Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates

Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus

DNA gag/Adenovirus Type 5 (Ad5) gag and Ad5 gag/Ad5 gag Vaccines Induce Distinct T-Cell Response Profiles

Comparative Cell-Mediated Immunogenicity of DNA/DNA, DNA/Adenovirus Type 5 (Ad5), or Ad5/Ad5 HIV-1 Clade B gag Vaccine Prime-Boost Regimens

Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay

All for one and one for all to fight flu

A replication-defective human cytomegalovirus vaccine for prevention of congenital infection

Efficacy of Multivalent Adenovirus-Based Vaccine against Simian Immunodeficiency Virus Challenge

International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials

Safety and Immunogenicity of the Merck Adenovirus Serotype 5 (MRKAd5) and MRKAd6 Human Immunodeficiency Virus Type 1 Trigene Vaccines Alone and in Combination in Healthy Adults

The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat

Vectored Gag and Env but Not Tat Show Efficacy against Simian-Human Immunodeficiency Virus 89.6P Challenge in Mamu-A01-Negative Rhesus Monkeys

Developing Vaccines for SARS-CoV-2 and Future Epidemics and Pandemics: Applying Lessons from Past Outbreaks

Suchergebnisse filtern